Primary cardiac tumors are rare with an incidence of less than 0.1%. Generally, metastasis of different types of cancers such as lung and breast cancers to the heart is over 20 times more common and has been reported to have a mortality rate of one in five patients in autopsies. According to the American Cancer Society (ASC), lung cancers accounted for about 1% -2% of all carcinoids. Every year, about 4,000 lung carcinoid tumors cases diagnosed in the United States. Only 25% of primary cardiac tumors are malignant and of this 75 % are sarcomas.
A noncancerous primary heart tumor can be removed surgically, whereas, treatment of malignant primary tumors is usually palliative (eg, radiation therapy, chemotherapy, management of complications) as the prognosis is poor. Patients with malignant primary tumors face a poor prognosis, and the treatment provided is often not directed at cardiac involvement but rather on treating the origin of cancer or providing palliative care.
Geographically, the global heart tumor market is categorized into regions such as the Americas, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
Geographically, the Americas heart tumor market is segmented into two major regions North Americas and South America. North America represents the largest market worldwide owing to the increasing healthcare expenditure. Europe has emerged as the second largest heart tumor market across the globe owing to the factors such as a rise in the demand for effective treatment of metastatic cancerous tumors such as lung, breast, and oesophageal cancers, high unmet needs for current treatment, and an increase in the research and development expenditure. These factors are expected to contribute to the growth of the global heart tumor market. The Asia Pacific is regarded as the fastest growing market.
Get Free Sample Copy of Report:https://www.marketresearchfuture.com/sample_request/5065
The heart tumor is segmented on the basis of type, diagnosis, and treatment.
On the basis of the type, the market is segmented into the primary tumor and secondary tumor. The primary tumors segment is divided into benign and malignant. The benign tumor is further categorized into myxoma, papillary heart tumors, fibromas, rhabdomyomas, angioma, and lipomas. The malignant tumors are divided into rhabdomyosarcoma, mesenchymomas, neurosarcoma, fusiform cell tumors, malignant heart hemangioma, and lymphosarcoma. The secondary tumor is categorized into metastatic and by contiguity.
The metastatic secondary tumors are divided into hematogenic and lymphatic and the contiguity is sub-categorized into mediastinal tumors, lung tumors and oesophageal or cardia tumor. On the basis of the diagnosis, the market is classified into Echocardiogram, Computed Tomography (CT) scan, Magnetic Resonance Imaging (MRI), Radionuclide imaging, Position Emission Tomography (PET) Scan, Myocardial Biopsy, Cardiac Catheterization, Electrophysiology Test. On the basis of the treatment, the market is classified as surgery, chemotherapy, radiation therapy. Furthermore, the surgery is further categorized into open heart surgery, minimally invasive surgery, heart transplant surgery
Get Covid-19 Impact Analysis on the Market:https://www.marketresearchfuture.com/enquiry/5065
The global market for heart tumor is expected to grow at a CAGR of approximately 7.1% during the forecast period 2017-2023.
Some of the key players in the global heart tumor market are Tomtec Imaging Systems GmBh, Koninklijke Philips N.V., Siemens Healthineers, Circle Cardiovascular Imaging Inc., Toshiba Corporation, Shimadzu Corporation, CardioComm Solutions Inc., Integer Holdings Corporation, Pie Medical Imaging, HeartSciences, 3mensio Medical Imaging, and eMedica, S.L.
Access Full Report Summary @https://www.marketresearchfuture.com/reports/heart-tumor-market-5065
Market Research Future
Office No. 528, Amanora Chambers
Pune – 411028
Phone: +1 646 845 9312
Market Research Future (MRFR) is a world-renowned market research company that offers a wide range of services, complete with accurate and precise analysis about diverse markets, sub-markets and target consumers. Our approach is a combination of extensive information and multiple data sources that help provide an exhaustive comprehension about the latest major developments to the client, in addition to future events and what measures and decisions to take on the basis of the same.
Our fast emerging market research firm is armed with an adept research analysts’ team that focuses on gathering useful data and analytics in terms of economic and technological advances. Our proficient analysts conduct industrial visits in a bid to achieve reliable and accurate information from established market participants. One of our foremost objectives is to keep the client well-versed with all the lucrative opportunities as well as challenges surrounding various global markets. We offer step-by-step guidance to our clients, through consulting and strategic services, enabling them to arrive at a practical and effective decision.